Global Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

SKU ID :GIR-10513559 | Published Date: 28-Aug-2017 | No. of pages: 122
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:
This report focuses on the Flu Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years

There are 15 Chapters to deeply display the global Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Flu Vaccine, with sales, revenue, and price of Flu Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
  • PRICE
  • $3480
    $4680
    Buy Now

Our Clients